HOME >> MEDICINE >> NEWS
Neurobiology of dread gives scientists clues about human decision making

ATLANTA -- In order to better understand how people make decisions when the outcomes are known to be unpleasant, a team of Emory neuroscientists led by Gregory Berns, MD, PhD, used functional magnetic resonance imaging (fMRI) to determine the areas of the brain that are activated when someone experiences dread. The study, which was supported by the National Institutes of Drug Abuse (NIDA), was published in the May 5, 2006 issue of the journal Science. The study was part of a research program in the growing field of neuroeconomics, an area in which neuroscience methods are being applied to economic questions.

"Most people don't like waiting for an unpleasant outcome, and want to get it over with as soon as possible," explains Dr. Berns, an associate professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine. "The only explanation for this is that the dread of having something hanging over your head is worse than the thing that you are dreading. It is a commonplace experience, but standard economic models of decision-making don't deal with this issue. So, we decided to take a biological approach and see what happens in the brain that might cause people to make such rash decisions."

The study was conducted using an fMRI scanner to look at the brains of the study participants while delivering a series of low voltage shocks to the foot of each participant, with different levels of intensity and different time delays up to the shock. Each of the participants in the study was screened to determine their maximal pain threshold. While in the MRI scanner, participants underwent a series of 96 shocks. Before each shock, they were told how painful the shock would be (as a percent of their threshold) and how long they would have to wait for it. After the scanning procedure, they were then given the opportunity to choose between different intensity-delay combinations, the choice was always between more pain s
'"/>

Contact: Kathi Baker
kobaker@emory.edu
404-727-9371
Emory University Health Sciences Center
4-May-2006


Page: 1 2 3

Related medicine news :

1. Once-dreaded leprosy replaced by tuberculosis, say researchers
2. Dyson Foundation gives $5 Million for ophthalmology research at Weill Cornell Medical College
3. Thymus transplants gives hope to babies with fatal immune disease
4. Plasmonics book gives overview of technology that could revolutionize computing
5. Study of leukemia survivors gives hints for better care
6. New Inteleos features gives users the ability to tailor information
7. Breast cancer treatment procedure gives women more options
8. Woodruff Foundation gives major boost to Emory Universitys strategic plan
9. Core needle biopsy gives an accurate picture of gene expression in whole tumor
10. NICE gives backing for the use of advanced biological therapies to treat severe psoriasis
11. National trial gives unprecedented support for steroid withdrawal in kidney transplants

Post Your Comments:
(Date:3/5/2015)... 05, 2015 Central Nebraska Imaging (CNI) ... including the brand’s new logo and optimized website. ... practice’s modern approach to expert diagnostic imaging, centered on ... be built to be a resource for Nebraska patients ... automated forms, communication and referral functionality, video content and ...
(Date:3/5/2015)... Santa Rosa, CA (PRWEB) March 05, 2015 ... Like a SuperPro! The series aims to teach viewers ... indoor garden with hydroponics. Grow Like a SuperPro takes you ... in between. From how to clone, to how to prune ... of growing. They are offering the whole series for download ...
(Date:3/5/2015)... March 05, 2015 Califia Farms ... announced at Natural Products Expo West that its popular ... 100 percent soy and dairy free. Califia Farms Vegan ... bottle and are packed with six grams of an ... includes fiber, B vitamins and magnesium. , Protein is ...
(Date:3/5/2015)... Diego, CA (PRWEB) March 05, 2015 ... the purest and most essential ingredients, the robust flavor ... of allergic reactions. PASCHA Chocolate is free from ... and sesame. Experience PASCHA's offering March 6th- 8th at ... Chocolate Spread. PASCHA Chocolate has broken new ground ...
(Date:3/5/2015)... 05, 2015 Today, Earth Source ... on 100% pollution-free electricity through a partnership with ... As an Arcadia Power Clean Energy Partner, ESO ... Power Partnership requirements, joining national brands such as ... clean energy. Earth Source Organics joins a growing ...
Breaking Medicine News(10 mins):Health News:Central Nebraska Imaging Center Gets Rebranding 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 2Health News:Califia Farms Vegan Protein and New Single Serve Almondmilks to Hit Supermarket Shelves this Month 3Health News:PASCHA Allergen Free Organic Chocolate to Appear at Natural Products Expo West March 6-8, 2015 2Health News:Earth Source Organics to Run on Clean Energy from Arcadia Power 2
(Date:3/5/2015)... and HAMPTON, N.J. , March ... MNK ), a leading global specialty biopharmaceutical ... announced today that they have entered into a definitive ... Ikaria, Inc. from a Madison Dearborn -led investor ... Subject to customary closing conditions, the ...
(Date:3/5/2015)... March 5, 2015  Asterias Biotherapeutics, Inc. (NYSE MKT: ... of regenerative medicine, announced today that Atlanta ... rehabilitation hospitals for spinal cord injury and brain injury, ... of AST-OPC1 (oligodendrocyte progenitor cells) in newly injured patients ... (SCI). The Phase 1/2a trial follows ...
(Date:3/5/2015)... March 5, 2015  MGC Diagnostics Corporation (NASDAQ: ... company, today reported financial results for the first ... 2015 first quarter domestic equipment, supplies and accessories ... $3.7 million in the 2014 first quarter.  During ... or $338,000 in revenue, compared to 14 accounts, ...
Breaking Medicine Technology:Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Initiates Patient Enrollment for Phase 1/2a Clinical Trial of AST-OPC1 in Newly Injured People with Complete Cervical Spinal Cord Injury 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 2MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 3MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 4MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 5MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 6MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 7MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 8MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 9MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 10MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 11MGC Diagnostics Corporation Reports Fiscal 2015 First Quarter Results 12
Cached News: